Computational studies on non-nucleoside analogs of pyrimidine as NNRTIs against HIV-1

被引:0
|
作者
Ritika Srivastava
Nidhi Singh
Anuradha Singh
Madhu Yadav
Ramendra K Singh
机构
[1] University of Allahabad,Nucleic Acids and Antiviral Research Laboratory, Department of Chemistry
关键词
Pyrimidine; Nevirapine; Nucleoside Analog; Docking Result; Formed Hydrogen;
D O I
10.1186/1471-2334-14-S3-E3
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses
    Rattanabunyong, Siriluk
    Choengpanya, Khuanjarat
    Suwattanasophon, Chonticha
    Kiriwan, Duangnapa
    Wolschann, Peter
    Lamtha, Thomanai
    Shaikh, Abdul Rajjak
    Rattanasrisomporn, Jatuporn
    Choowongkomon, Kiattawee
    JOURNAL OF VETERINARY SCIENCE, 2023, 24 (05)
  • [42] Design, synthesis and biological evaluation on N- heteroaryl compounds as probable NNRTIs against laboratory adapted strains and the primary isolates of HIV-1
    Anuradha Singh
    Madhu Yadav
    Ritika Srivastava
    Nidhi Singh
    Ashwini Godse
    Rahul Suryawanshi
    Ashwini Dhamanage
    Smita Kulkarni
    Ramendra K Singh
    BMC Infectious Diseases, 14 (Suppl 3)
  • [43] Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients
    Macias, Juan
    Neukam, Karin
    Mellolas, Josep
    Lopez-Cortes, Luis F.
    Carton, Jose A.
    Domingo, Pere
    Moreno, Santiago
    Iribarren, Jose A.
    Clotet, Bonaventura
    Crespo, Manell
    de Los Santos, Ignacio
    Ortega, Enrique
    Knobel, Hernando
    Jimenez-Exposito, Maria J.
    Pineda, Juan A.
    HIV CLINICAL TRIALS, 2012, 13 (02): : 61 - 69
  • [44] Structure-based non-nucleoside inhibitor design: Developing inhibitors that are effective against resistant mutants
    Smith, Steven J.
    Pauly, Gary T.
    Hewlett, Katharine
    Schneider, Joel P.
    Hughes, Stephen H.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 97 (01) : 4 - 17
  • [45] Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
    Anta, Lourdes
    Llibre, Josep M.
    Poveda, Eva
    Blanco, Jose L.
    Alvarez, Marta
    Perez-Elias, Maria J.
    Aguilera, Antonio
    Caballero, Estrella
    Soriano, Vicente
    de Mendoza, Carmen
    AIDS, 2013, 27 (01) : 81 - 85
  • [46] Cost Assessment of Antiretroviral Drugs Used in the Treatment of Patients with HIV InfectionFocus on Non-Nucleoside Reverse Transcriptase Inhibitors
    Sergio Sabbatani
    Raffaella Cesari
    Clinical Drug Investigation, 2002, 22 : 253 - 262
  • [48] Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs
    Rai, Diwakar
    Chen, Wenmin
    Tian, Ye
    Chen, Xuwang
    Zhan, Peng
    De Clercq, Erik
    Pannecouque, Christophe
    Balzarini, Jan
    Liu, Xinyong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (23) : 7398 - 7405
  • [49] The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients
    Bain, A. M.
    Payne, K. D.
    Rahman, A. P.
    Bedimo, R.
    Maclayton, D. O.
    Rodriguez-Barradas, M.
    Busti, A. J.
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2008, 4 (02) : 147 - 151
  • [50] Pharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: Influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments
    Russo, Gianluca
    Paganotti, Giacomo Maria
    Soeria-Atmadja, Sandra
    Haverkamp, Miriam
    Ramogola-Masire, Doreen
    Vullo, Vincenzo
    Gustafsson, Lars Lennart
    INFECTION GENETICS AND EVOLUTION, 2016, 37 : 192 - 207